[°ûÁöÇý] [±×·ì °è¿­»ç] mRNA Project Leader ¸ðÁý

Date 07/02/2021   Hits 738

1. ¼Ò¼Ó ÇìµåÇåÆà ȸ»ç¸í: Á¦ÀÌ¿¡ÀÌÄ¡¿¡ÀÌÄ¡¾Ë-JHHR /
ÁÖ¼Ò : ¼­¿ï½Ã °­¼­±¸ ¸¶°îÁß¾Ó 6·Î 21
2. ¼Ò¼Ó ÇìµåÇåÆûç ȨÆäÀÌÁö: http://www.jhhr.co.kr
3. ¼Ò¼Ó ÇìµåÇåÆûç ȸ»ç ÀüÈ­¹øÈ£: 82-2-567-7407 (Á÷Åë)
4. ¼Ò¼Ó ÇìµåÇåÆûç ȸ»ç¿ë, À̸ÞÀÏ : jhkwak@jhhr.co.kr
5. Æ÷Áö¼Ç ÁøÇà ÇìµåÇåÅÍ¸í ¹× Á÷±Þ : °û Áö Çý ´ëÇ¥ ÄÁ¼³ÅÏÆ®


[±×·ì °è¿­»ç] mRNA Project Leader ¸ðÁý

1.ÀÇ·Ú»ç:[±×·ì °è¿­»ç] - Á¦¾à ¹× ¹ÙÀÌ¿À

¢Ã Position : [±×·ì °è¿­»ç] mRNA Project Leader ¸ðÁý


[ÀÚ°Ý¿ä°Ç]

- Prior research experience in biotech or pharmaceutical industry is required, in particular the therapeutic application of mRNA or CRISPR/CAS technologies towards IND filing
- Proven track record of leading mRNA programs through IND-enabling studies into clinical development
- Sound experience with mRNA therapeutics and in vivo delivery concepts (such as lipid nanoparticles)
- Ability to move projects forward and produce data on time
- Proficiency in the relevant areas of natural and synthetic mRNA biology (DNA, mRNA, protein)
- Understanding how medicinal chemistry efforts enhance mRNA performance
- Familiarity with a broad range of bioanalytical, molecular biology methods or biochemical assays to characterize mRNA and its impact on disease progression (such as ELISA, MSD, Flow Cytometry, RT-PCR, Nanostring)
- Capacity to identify and solve problems
- Excellent oral and written communication skills
- Motivation to work independently as part of a very collaborative, international team



[Á÷¹«³»¿ë]


- Strategic leader of one (or more) mRNA projects in the areas of immuno/oncology, infectious diseases or vaccination program
- Integration of company decisions and business considerations into the project
- Prioritization of program key objectives, data reviews and milestone deliverables
- Adapting the mRNA therapeutic property to the selected disease profile, increasing the chance of successful treatment in patients
- Monitoring changing regulatory requirements, as well as competitive landscape
- Collaboration within the mRNA group, as well across other functions
- As a team effort, identification of animal models for Non-GLP and GLP toxicology studies
- Demonstration of efficacy, durability and safety (especially immuno-safety) for innovative mRNA therapeutics and delivery vehicles, leading to identification of lead molecules within timelines
- Collect, analyze and document experimental data
- Present the final results to team members and line manager
- The successful candidate is expected to do hands-on bench work as requested




¢Ã Á¦Ãâ¼­·ù: ±¹¹® À̷¼­ ¹× »ó¼¼ °æ·Â ±â¼ú¼­

¢Ã ÁøÇàÀýÂ÷ : 1Â÷ ¼­·ù ÀüÇü- 2Â÷ ¸éÁ¢ÀüÇü - 3Â÷ ÃÖÁ¾¸éÁ¢

¢Ã ´ã´çÀÚ: °ûÁöÇý
¿¬¶ôó : 82-2-567-7407(Á÷Åë)
À̸ÞÀÏ : jhkwak@jhhr.co.kr